Veerhealth Care Ltd strategy deck summary

Strategy deck of 27 Jun 2026, summarised by AI from the filing.

Veerhealth Care projects net sales of ₹102.98 cr in FY27 and ₹152.47 cr in FY28, after Q4 FY26 revenue of ₹16.76 cr.

Key takeaways

1. Q4 revenue Revenue from operations ₹16.76 cr in Q4 FY26 (Q3 FY26: ₹7.26 cr; Q4 FY25: ₹5.62 cr).
2. Net sales guidance Net sales projected at ₹102.98 cr in FY27 and ₹152.47 cr in FY28 (FY25-26: ₹32.48 cr).
3. FMCG client Recently onboarded a leading FMCG company in the 'personal and household care' segment, part of a 125 year old business group.
4. USFDA approval USFDA approval received in June 2025 for Drug (OTC) products, making the company eligible to export to the U.S.
5. Forward-looking risk Forward-looking statements are not a guarantee of future performance and are subject to known and unknown risks and uncertainties.

Original filing on BSE

Veerhealth Care Ltd earnings call, investor presentation and press release summaries

• Q4 FY26: Results press release (2 Jun 2026)
• Q3 FY26: Results press release (16 Feb 2026)
• Q1 FY26: Results press release (13 Aug 2025)
• Other events: Strategy deck (27 Jun 2026), Strategy deck (25 Feb 2026)